Publication date: Aug 01, 2024
Societal changes secondary to the coronavirus disease 2019 pandemic led to increased prevalence of adolescents with obesity and heightened awareness of weight stigma and size bias. During this time the American Academy of Pediatrics published its first clinical practice guidelines, and the Food and Drug Administration approved new weight loss drugs for adolescents, but insurance coverage is largely unavailable.
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Obesity |
| disease | MESH | coronavirus disease 2019 |
| disease | VO | time |
| disease | MESH | weight loss |
| disease | MESH | Pediatric Obesity |
| drug | DRUGBANK | Semaglutide |
Original Article
(Visited 3 times, 1 visits today)